$11.51
0.02880.25%
Last update: Feb 18, 10:34 AM
Comments
Loading...
Korro Bio Inc Earnings Estimates
KRRONASDAQ
Korro Bio Earnings Estimates, EPS & Revenue | NASDAQ:KRRO
Korro Bio (KRRO) is scheduled to report Q4 earnings on March 17, 2026. Analysts estimate EPS of $-2.05 and quarterly revenue of $855.00K.
In the most recent quarter (Q3), Korro Bio reported EPS of $-1.92, beating estimates of $-2.65 by 0.28%. Revenue came in at $1.09M, exceeding the estimate of $846.94K by 0.29%.
Over the last 4 quarters, Korro Bio has averaged an EPS surprise of 0.13% and a revenue surprise of 7.24%.
Earnings Date
Mar 17
EPS Estimate
$-2.050
Quarterly Revenue Estimate
$855.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$7.37M
Korro Bio Earnings History
Analyze the earnings history of Korro Bio using advanced sorting and filters.
Korro Bio (KRRO) Earnings Per Share
The chart below shows Korro Bio's reported EPS compared to analyst estimates over recent quarters.
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $-1.92 | $-2.65 | 27.6 % |
| Q2 | 2025-08-12 | $-2.74 | $-2.57 | -6.61 % |
| Q1 | 2025-05-07 | $-2.49 | $-2.65 | 6.04 % |
| Q4 | 2025-03-18 | $-2.26 | $-2.51 | 9.96 % |
Korro Bio (KRRO) Revenue
The chart below shows Korro Bio's reported revenue compared to analyst estimates over recent quarters.
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-12 | $1.09M | $846.94K | 28.7 % |
| Q2 | 2025-08-12 | $1.46M | $406.90K | 258.8 % |
| Q1 | 2025-05-07 | $2.55M | $128.57K | 1883.4 % |
FAQ
When is Korro Bio (NASDAQ:KRRO) reporting earnings?
Korro Bio (KRRO) is scheduled to report earnings on May 6, 2026. The last reported earnings were for reported on November 12, 2025 for Q3.
What were the latest earnings per share (EPS) for Korro Bio (NASDAQ:KRRO)?
The Actual EPS was $-1.92, which beat the estimate of $-2.65.
What were Korro Bio’s (NASDAQ:KRRO) revenues?
The Actual Revenue was $1.09M, which beat the estimate of $846.94K.
